Member Info for DSFLAT

Hi ERCFC,

I would suggest the recent decline in sp has been mostly due to the Convid diagnosis fall off in interest..

That said there are now blood clot issues which GDR has a diagnostic system Genedrive CYP2C19 that could save lives

Near term it's about the Genedrive® MT-RNR1 Test
http://www.genedriveplc.com/news/press-releases.php

Perhaps the Point-of-Care Genedrive® COV19-ID Kit receives Coronavirus Test Device will prove to be of great value but for me the Dury is out on that (for now)

This may be of help:
http://www.genedriveplc.com/news/press-releases.php

I've now added three buys today (obviously run out of Blue ink)

Shared my thoughts of Multi Bagger in the making with Argonauts (ARB)

I did well there a few years ago and they have been decimated so I hope this may bring some gains (I bloody hope so, the last thing I need is a bunch of Argonauts hounding me for evermore :)

I remember that feeling when I had loaded Argo at 5.65p, again at 7p, 8p, 10p and 12p before it went to £3 ish ....

I have a similar feeling about Genedrive (GDR)

There are some good posts on there today, might be worth a look ;-)

This post will probably get deleted but if GDR Moons in the coming months I can at least say I tried

GLA

A world-first genetic test that could save the hearing of hundreds of babies each year has been developed and successfully piloted in the NHS.
Professor Dame Sue Hill, Chief Scientific Officer for England and Senior Responsible Officer for Genomics in the NHS, said: “Genomic medicine is transforming healthcare, and this is a powerful example of how genetic testing can now be done extremely quickly and become a vital part of triage – not only in intensive care but across our services.

Backed by £900,000 funding from the National Institute for Health Research (NIHR) and support from the charity Royal National Institute for Deaf People, the Genedrive System, which costs £80 per baby, was developed by Genedrive, a start-up based at the University of Manchester. It was developed in close collaboration with Professor Newman’s team at Manchester Biomedical Research Centre.

https://www.england.nhs.uk/2022/04/nhs-develops-world-first-bedside-genetic-test-to-prevent-babies-going-deaf/

I've added a couple of times today but found myself racking my brains why the SP wasn't already higher, so I've been doing more DD and I still have no idea why the sp isn't much higher

This has Multi, Multi Bagger written all over it (imo)

RNS Number : 7594B
"The US is a particularly attractive market for this unique test given the potential to save hundreds of individuals from life-long deafness and reduce litigation costs relating to the unwanted side effects from antibiotic use on those carrying the gene variant. Either an FDA 510(k) clearance or the granting of a De Novo request is required to allow us to market this test in the US. Ultimately, we feel that the US market is potentially the most attractive market given its size, birth rates, use of diagnostic testing and reimbursement structure."

Do we know the reimbursement structure GDR will likely receive for testing in the UK using an estimated 90,000 babies treated in the UK per year according to Bill Newman, clinical geneticist and professor at the University of Manchester?

And does anyone have any ballpark reimbursement figures using; 2021, 3.7 million babies were born in the USA, with 10.5% born prematurely?

From RNS Number : 2587C

$0.5m upfront, $0.5m on completion of the, already fully financed, Evgen-sponsored human volunteer Phase 1 study (anticipated during Q2 2023).
Milestone payments up to commercial launch are $26.5m, including $5m on grant of IND by the FDA (anticipated in late 2023).
Total milestones of $160.5m are payable to the Company in relation to the first neurodevelopmental disorder indication under the license.
Royalties payable to Evgen on sales are in the low to medium double-digit range in all scenarios, including on-licensing by Stalicla and use of SFX-01 in further licensed indications.

Just posting for any new eyes looking in on EVG today

Thanks for that share 1DayRodney

Potential impact
In theory, as seven million babies are treated with gentamicin worldwide per year, there is the potential to avoid hearing loss in 14,000 babies annually. Because of the specific way this genetic variant is inherited (it is present in the mitochondrial genome), it will be passed by a mother to all her children, both male and female. Her siblings and mother will also carry the variant. It is important that this information is disseminated within the family so that alternatives to gentamicin can be prescribed as indicated.

Rollout throughout neonatal units across the NHS is under advanced discussion with commissioning teams, and we envisage that this test will be available to all at-risk babies in the next two years.

90,000 babies treated in the UK per year according to Bill Newman, clinical geneticist and professor at the University of Manchester:
https://vimeo.com/393967693

I've sent an email requesting 7digital consider some interviews with the likes of Proactive, Share Talk and Vox Markets.

Seems to be a lack of marketing on that front (imo)

Perhaps others who feel the same way could nudge them a little in that direction...

Pinterest contract would suggest 7digital tech is good...

The business model and historic share price decline would suggest improvements could and should be made (imo)

YOLO'd in yesterday and will hold to see how the Pinterest deal pans out or if someone takes over 7DIG because they have deeper pockets and know how to build this business into something much bigger.

No price monitoring RNS's today ....

mm's should be called in to explain themselves

I'm still buying the dips ;-) BTFD

I'd expect some hefty late trades today..

Very small trades printed but mm's playing the game imo

BTFD (i'm buying every dip ;)

'Ladbrokes'

Bloody Whiskey ;-)

EoA a good friend of mine (former FD of Ladbrooks) once said to me

'It's not about what you've got it's about what you could have'

He did better that OK when Coral bought Ladbrooks...

Just saying ;-)

Earl of shaim may have already scared some investors out of todays gains ...

Jeez the RNS only landed a few hours ago, give to doom posts a rest ffs

Big money must still be watching the TV trustonomics nonsense

Fine by me, BTFD ;-)

RNS only landed two hours ago while many were watching the trustonomics play out

only 400 trades so far which suggests there are thousands of trades yet to land here ;-)

Some Ed Sheeran to accompany today's news ;-)

Ed Sheeran - Bloodstream (Live at The BRIT Awards 2015)
'Tell me when it kicks in'
https://youtu.be/c4-SAgfVLUY

HL £500 max single purchases available ...

High excess deaths in Australia
2022, deaths up to 30 June
92,699
13,524 (17.1%) more than the historical average

'They' are labelling as much as 'They' can as Convid but those with eyes know it's the jabs causing the deaths and who knows what long term effects...

Still early in the Convid911 story and plenty of time for GDR to come to the rescue ;-)

https://youtu.be/xRCv_Wh5njM

sledgey121 this companies product can save children from a life of hearing loss

Can perhaps save the lives of the many who took the falsely advertised mRNA injections

I'm invested for the right reasons....